CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study

Seong Hoon Shin, Ho Sup Lee, Yang Soo Kim, Young Jin Choi, Sung Hyun Kim, Hyuk Chan Kwon, Sung Yong Oh, Jung Hun Kang, Chang Hak Sohn, Sang Min Lee, Jin Ho Baek, Young Joo Min, Choongrak Kim, Joo Seop Chung

Cancer Research and Treatment. 2014;46(4):331-338. Published online 2014 July 21 DOI: https://doi.org/10.4143/crt.2013.130

Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study

Cancer Research and Treatment. 2014;46(4):331-338

Link1

Link2

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

Magdi Hanna, Alberto Tuca, John Thipphawong

BMC Palliative Care. 2009;8(1):

Link1

Link2 Link3 Link4

Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain

Sharon M. Weinstein, Minggao Shi, Barbara J. Buckley, Monica A Kwarcinski

Clinical Therapeutics. 2006;28(1):86-98

Link1 Link2

Poster 269: Open‐label Extension Study on the Long‐Term Safety, Impact on Quality of Life and Clinical Utility of OROS^® Hydromorphone Extended Release in Patients with Chronic Low Back Pain

Mark S. Wallace, John Thipphawong

PM&R. 2009;1(9S):

Link1 Link2 Link3 Link4

1161 Tasimelteon Shows Persistence Of Efficacy In Improving Sleep Disturbances In Patients With Smith-Magenis Syndrome (SMS) In Open-Label Extension Study

J Brooks, M Gibson, K Kite, E Czeisler, M Fisher, C Xiao, C Polymeropoulos, M Polymeropoulos

Sleep. 2020;43(Supplement_1):A442-A444

Link1

Link2

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

Cheol Kyu Park, Hyun-Wook Kang, In-Jae Oh, Young-Chul Kim, Yeo-Kyeoung Kim, Kook-Joo Na, Sung-Ja Ahn, Tae Ok Kim, Young Jin Choi, Geun Am Song, Min Ki Lee

Journal of Korean Medical Science. 2016;31(12):1914

Link1 Link2 Link3

Open-label extension study on the long-term efficacy, safety, and impact on quality of life of OROS® hydromorphone extended release in patients with chronic low back pain

M. Wallace, J. Thipphawong

The Journal of Pain. 2009;10(4):S49

Link1 Link2

Open-Label Study on the Long-Term Efficacy, Safety, and Impact on Quality of Life of OROS Hydromorphone ER in Patients with Chronic Low Back Pain

Mark Wallace, John Thipphawong

Pain Medicine. 2010;11(10):1477-1488

Link1

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

Stefan Pfennigsdorf, Ramez, von Kistowski, Mäder, Eschstruth, Froböse, U Thelen, Spraul, D Schnober, Cooper, Laube

Clinical Ophthalmology. 2012;739

Link1

Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis

Martin Hale, Iulia Cristina Tudor, Sarita Khanna, John Thipphawong

Clinical Therapeutics. 2007;29(5):874-888

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.